155 related articles for article (PubMed ID: 23341957)
1. Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.
Das S; Shetty RK; Kumar A; Shridharan RN; Tatineni R; Chi G; Mukherjee A; Das S; Subbarao SM; Karande AA
PLoS One; 2013; 8(1):e53619. PubMed ID: 23341957
[TBL] [Abstract][Full Text] [Related]
2. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
3. A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.
Desombere I; Mesalam AA; Urbanowicz RA; Van Houtte F; Verhoye L; Keck ZY; Farhoudi A; Vercauteren K; Weening KE; Baumert TF; Patel AH; Foung SKH; Ball J; Leroux-Roels G; Meuleman P
Antiviral Res; 2017 Dec; 148():53-64. PubMed ID: 29074219
[TBL] [Abstract][Full Text] [Related]
4. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.
Das S; Mullick R; Kumar A; Tandon H; Bose M; Gouthamchandra K; Chandra M; Ravishankar B; Khaja MN; Srinivasan N; Das S; Melkote Subbarao S; Karande AA
J Gen Virol; 2017 May; 98(5):962-976. PubMed ID: 28221101
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
Mesalam AA; Desombere I; Farhoudi A; Van Houtte F; Verhoye L; Ball J; Dubuisson J; Foung SKH; Patel AH; Persson MAA; Leroux-Roels G; Meuleman P
Virology; 2018 Jan; 514():30-41. PubMed ID: 29128754
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human monoclonal antibodies to the envelope e2 protein of hepatitis C virus and their characterization.
Shimizu YK; Hijikata M; Oshima M; Shimizu K; Alter HJ; Purcell RH; Yoshikura H; Hotta H
PLoS One; 2013; 8(2):e55874. PubMed ID: 23409074
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
[TBL] [Abstract][Full Text] [Related]
9. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
[TBL] [Abstract][Full Text] [Related]
12. Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection.
Rafique S; Idrees M; Ali A; Iqbal M
Mol Biol Rep; 2014 Jun; 41(6):3945-50. PubMed ID: 24566682
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.
Ashfaq UA; Qasim M; Yousaf MZ; Awan MT; Jahan S
J Transl Med; 2011 Nov; 9():194. PubMed ID: 22074322
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
[TBL] [Abstract][Full Text] [Related]
15. In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection.
Mailly L; Wrensch F; Heydmann L; Fauvelle C; Brignon N; Zeisel MB; Pessaux P; Keck ZY; Schuster C; Fuerst TR; Foung SKH; Baumert TF
Antiviral Res; 2019 Feb; 162():136-141. PubMed ID: 30599173
[TBL] [Abstract][Full Text] [Related]
16. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S
Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891
[TBL] [Abstract][Full Text] [Related]
17. No requirement of HCV 5'NCR for HCV-like particles assembly in insect cells.
Zhao W; Liao GY; Jiang YJ; Jiang SD
World J Gastroenterol; 2003 Oct; 9(10):2226-31. PubMed ID: 14562383
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
[TBL] [Abstract][Full Text] [Related]
19. Development of an effective single-chain variable fragment recognizing a novel epitope in the hepatitis C virus E2 protein that restricts virus entry into hepatocytes.
Das S; Behera P; Shewale DJ; Bodele J; Das S; Karande AA
Arch Virol; 2024 Apr; 169(5):112. PubMed ID: 38683226
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity.
Keck ZY; Sung VM; Perkins S; Rowe J; Paul S; Liang TJ; Lai MM; Foung SK
J Virol; 2004 Jul; 78(13):7257-63. PubMed ID: 15194801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
